
GPN Vaccines reports strong immunogenicity data in older adults independent of previous pneumococcal vaccination status with good tolerability and sustained immunogenicity
Adelaide, Australia, 14th July 2025 GPN Vaccines Ltd, a clinical-stage biotechnology company developing a Streptococcus pneumoniae vaccine to…